Lv2
190 积分 2024-02-06 加入
Exploring the next generation of antibody–drug conjugates
19小时前
待确认
Treatment of NSCLC after chemoimmunotherapy — are we making headway?
1天前
已完结
PD-1–targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer
1个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25(+)CD8(+) T cells
1个月前
已完结
Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant immunochemotherapy in gastric cancer
1个月前
已完结
Profiling phagosome proteins identifies PD-L1 as a fungal-binding receptor
2个月前
已完结
A single inhibitor for all KRAS mutations
3个月前
已完结
Pooled analysis by best confirmed response to trastuzumab deruxtecan and related biomarkers in patients with HER2-positive metastatic breast cancer from DESTINY-Breast01, DESTINY-Breast02, and DESTINY-Breast03
3个月前
已完结
Pharmacodynamic-Mediated Drug Disposition (PDMDD) Model of Daratumumab Monotherapy in Patients with Multiple Myeloma
3个月前
已完结
皖公网安备34019202002308
